Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5941 AL 5955

Resumption of food and fluid intake in Alzheimer's disease with severe apathy following intravenous citalopram

Hellen F, Supprian T, Salamon T, Lange-Asschenfeldt C.

Psychiatry Clin Neurosci. 2012 Feb;66(1):82. doi: 10.1111/j.1440-1819.2011.02294.x.

Nonhuman primate models of Alzheimer-like cerebral proteopathy

Heuer E, Rosen RF, Cintron A, Walker LC.

Curr Pharm Des. 2012;18(8):1159-69. doi: 10.2174/138161212799315885.

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment

Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M.

Neurodegener Dis. 2012;10(1-4):285-93. doi: 10.1159/000335154. Epub 2012 Feb 10.

Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?

Levy K, Lanctôt KL, Farber SB, Li A, Herrmann N.

Drugs Aging. 2012 Mar 1;29(3):167-179. doi: 10.2165/11599140-000000000-00000.

Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease

Aisen PS, Cummings J, Schneider LS.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006395. doi: 10.1101/cshperspect.a006395.

Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease

McLaren DG, Sreenivasan A, Diamond EL, Mitchell MB, Van Dijk KR, Deluca AN, O'Brien JL, Rentz DM, Sperling RA, Atri A.

Neurodegener Dis. 2012;9(4):176-86. doi: 10.1159/000335876. Epub 2012 Mar 27.

Alzheimer's disease 2012: the great amyloid gamble

Marchesi VT.

Am J Pathol. 2012 May;180(5):1762-7. doi: 10.1016/j.ajpath.2012.03.004. Epub 2012 Apr 1.

Ethical issues in Alzheimer's disease: an overview

Leuzy A, Gauthier S.

Expert Rev Neurother. 2012 May;12(5):557-67. doi: 10.1586/ern.12.38.

Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine

Doody RS, Geldmacher DS, Farlow MR, Sun Y, Moline M, Mackell J.

Dement Geriatr Cogn Disord. 2012;33(2-3):164-73. doi: 10.1159/000338236. Epub 2012 May 10.

A novel subject synchronization clinical trial design for Alzheimer's disease

Schultz T, Yang E, Farnum M, Lobanov V, Verbeeck R, Raghavan N, Samtani MN, Novak G, Shi Y, Narayan V, DiBernardo A.

J Alzheimers Dis. 2012;31(3):507-16. doi: 10.3233/JAD-2012-120286.

Practical lessons from amyloid immunotherapy trials in Alzheimer disease

Solomon A, Akenine U, Andreasen N, Mangialasche F, Wimo A, Jelic V, Kivipelto M, Winblad B.

Curr Alzheimer Res. 2012 Dec;9(10):1126-34. doi: 10.2174/156720512804142958.

Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery

Wahlberg LU, Lind G, Almqvist PM, Kusk P, Tornøe J, Juliusson B, Söderman M, Selldén E, Seiger Å, Eriksdotter-Jönhagen M, Linderoth B.

J Neurosurg. 2012 Aug;117(2):340-7. doi: 10.3171/2012.2.JNS11714. Epub 2012 Jun 1.

Alzheimer's disease: early diagnosis and treatment

Chu LW.

Hong Kong Med J. 2012 Jun;18(3):228-37.

Safety and biomarker effects of solanezumab in patients with Alzheimer's disease

Farlow M, Arnold SE, van Dyck CH, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, Siemers ER.

Alzheimers Dement. 2012 Jul;8(4):261-71. doi: 10.1016/j.jalz.2011.09.224. Epub 2012 Jun 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias